Singapore: +65-31631880 | India: +91-40-42023318
  U.S / Canada Toll Free: +1-866-259-4781
  Kenya: +254-732-300719


Clinical Trial News

Clinical trial demonstrates success of low FODMAP diet

A change in diet can improve the lives of those diagnosed with a common, but hard-to-treat gut disorder.

New Phase 3 study findings show Stelara maintained clinical remission after one year of treatment in patients with moderate to severe Crohn's disease

Janssen Research & Development, LLC (Janssen) Phase 3 data presented for the first time at Digestive Disease Week® 2016 showed that a significantly greater proportion of adult patients with...

Surgeons trial new drug to help brain haemorrhage patients

Surgeons in Southampton are trialling a new drug based on a chemical found in broccoli to try to improve outcomes for brain haemorrhage patients.

Novel trial approaches may help to make cancer treatments more precise

Newer trial designs may help to personalize cancer treatments based on DNA alterations in tumors, rather than on primary tumor site or stage of disease.

New data show that tiotropium helps children with their asthma symptoms by improving lung function in comparison to placebo

New data from the Phase III VivaTinA-asthma® study show that when used as an add-on to maintenance asthma therapy (inhaled corticosteroid, ICS, or ICS plus another maintenance therapy)...

Clinical trial underway for treatment of sleep apnea in adolescents with Down syndrome

New technology may benefit unique population of patients who cannot tolerate CPAP machines.

Modeling and simulation help optimize chemotherapy to combat brain tumor

St. Jude Children's Research Hospital scientists have used sophisticated pharmacologic modeling and simulation to translate preclinical findings into a successful phase I clinical trial of a...

Alzheimer's researchers cast a broader net to find a cure

Two doctors from Danish international pharmaceutical company Lundbeck write about the challenges researchers face in uncovering a much-needed cure for Alzheimer's.

James Lind Institute Newsletter
James Lind Institute Linkedin
James Lind Institute RSS
James Lind Institute Email Update
James Lind Institute Blog
James Lind Institute Facebook